Kei Itagaki

Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders

Chiyo Shibasaki, Minoru Takebayashi, Kei Itagaki et al. · The International Journal of Neuropsychopharmacology · 2016 · 55 citations · Full text

Medicine, Psychiatry, Clinical Biochemistry +12

Identification of Lysophosphatidic Acid Receptor 1 in Astroglial Cells as a Target for Glial Cell Line-derived Neurotrophic Factor Expression Induced by Antidepressants

Naoto Kajitani, Kanako Miyano, Mami Okada‐Tsuchioka et al. · Journal of Biological Chemistry · 2016 · 30 citations · Full text

Life Sciences, Neurobiology, Neuroscience +9

Factors associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar depression

Kei Itagaki, Minoru Takebayashi, Chiyo Shibasaki et al. · Journal of Affective Disorders · 2016 · 28 citations

Medicine, Pharmacotherapy, Psychiatry +13

Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder

Kei Itagaki, Minoru Takebayashi, Hiromi Abe et al. · The International Journal of Neuropsychopharmacology · 2019 · 23 citations · Full text

Medicine, Immunology, Psychiatry +17

Possible Association between Serum Matrix Metalloproteinase-9 (MMP-9) Levels and Relapse in Depressed Patients following Electroconvulsive Therapy (ECT)

Chiyo Shibasaki, Kei Itagaki, Hiromi Abe et al. · The International Journal of Neuropsychopharmacology · 2017 · 21 citations · Full text

Medicine, Psychiatry, Adult Psychiatry +12